Skip to content

A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms

The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02413437
Enrollment
2088
Registered
2015-04-09
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Neoplasms

Keywords

contrast-enhanced ultrasound, biopsy

Brief summary

The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.

Detailed description

The patients with liver neoplasms who need receive percutaneous biopsy were randomized into contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims include: 1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US group. 2. Comparison the diagnostic accuracy rate specificity and sensitivity between smaller(\<3cm) and larger(≥3cm) nodule group. 3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy. 4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared with conventional ultrasound guided biopsy.

Interventions

OTHERCEUS guided biopsy

Biopsy was operated under contrast-enhanced ultrasound-guided.

OTHERUS guided biopsy

Biopsy was operated under conventional ultrasound-guided.

DEVICEUltrasound

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with liver occupied lesion who cannot be diagnosed by imaging examination or need pathological results

Exclusion criteria

* severe anemia * PLT\<60000/mm3,prothrombin activityprothrombin time activity\<70% * women during menstruation, pregnancy, child birth and baby nursing period * patients with severe mental disorder * cardiopulmonary failure

Design outcomes

Primary

MeasureTime frameDescription
diagnostic accuracy12 monthsdiagnostic accuracy=(true positive+ ture negative)/number of parcitipants

Countries

China

Contacts

Primary ContactKun Yan, master
ydbz@vip.sina.com0086-10-88196910
Backup ContactWei Wu, doctor
wuvei@163.com0086-10-88196140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026